美国紫杉生物制药集团，通过其实体经营，哈尔滨红豆杉科技开发有限责任公司（HDS），是一个红豆杉原料的种植大户及红豆杉树和手工艺品的销售厂家。我们销售的红豆杉原料，包括红豆杉树的枝叶，在中国用于生产传统的中国医药（中药），已被中国传统医学批准为某些癌症的辅助治疗材料，这意味着它必须与其他药品进行组合。
由公司的创始人及总裁王志国先生研究、发明的加速增长技术的专利，结合无性繁育方法，可以使红豆杉树的生长成熟在2-3年内完成，而天然红豆杉树繁育需要50年以上成熟。
-
2015 First Quarter Earnings Release
- No Events Currently Scheduled
简单的事实
Founded in 1996 as a state owned enterprise to grow and cultivate yew trees on land near Harbin and incorporated under the laws of the People’s Republic of China.
Became a publicly traded company in the U.S. in 2013
Began trading Over-the-counter in the U.S. under the symbol YEWB
A leading producer of Yew Trees
We have successfully cultivated more than eight million yew nursery seedlings in four nurseries. These nurseries occupy approximately 19,759 Mu (approximately 2,957 acres) of forested land and we currently have the capacity to grow up to two million yew nursery seedlings annually.
电子邮件报名